O. Güler Et Al. , "The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005," ASTRO 2022 , vol.114, Texas, United States Of America, pp.159-160, 2022
Güler, O. Et Al. 2022. The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005. ASTRO 2022 , (Texas, United States Of America), 159-160.
Güler, O., Oymak, E., Yazıcı, G., Ozkaya Akagunduz, O., Çetinayak, H. O., Erpolat, P., ... Aksoy, A.(2022). The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005 . ASTRO 2022 (pp.159-160). Texas, United States Of America
Güler, O.C Et Al. "The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005," ASTRO 2022, Texas, United States Of America, 2022
Güler, O.C Et Al. "The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005." ASTRO 2022 , Texas, United States Of America, pp.159-160, 2022
Güler, O. Et Al. (2022) . "The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005." ASTRO 2022 , Texas, United States Of America, pp.159-160.
@conferencepaper{conferencepaper, author={O.C Güler Et Al. }, title={The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005}, congress name={ASTRO 2022}, city={Texas}, country={United States Of America}, year={2022}, pages={159-160} }